02.12.2021 09:24:15

DGAP-DD: PharmaSGP Holding SE english




Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

02.12.2021 / 09:23
The issuer is solely responsible for the content of this announcement.








1. Details of the person discharging managerial responsibilities / person closely associated

a) Name




Name and legal form: FUTRUE GmbH

2. Reason for the notification

a) Position / status




Person closely associated with:
Title: Dr.
First name: Clemens
Last name(s): Fischer
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
PharmaSGP Holding SE

b) LEI
3912005CZ12PVVCIPT91 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code




Type: Share
ISIN: DE000A2P4LJ5

b) Nature of the transaction


Acquisition

c) Price(s) and volume(s)




Price(s) Volume(s)
25.50 EUR 5508000.00 EUR

d) Aggregated information




Price Aggregated volume
25.50 EUR 5508000.00 EUR

e) Date of the transaction
30/11/2021; UTC+1

f) Place of the transaction




Outside a trading venue



02.12.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
















Language: English
Company: PharmaSGP Holding SE
Lochhamer Schlag 21
82166 Gräfelfing
Germany
Internet: https://pharmasgp.com



 
End of News DGAP News Service





71328  02.12.2021 



fncls.ssp?fn=show_t_gif&application_id=1253399&application_name=news&site_id=smarthouse

Analysen zu PharmaSGPmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

PharmaSGP 23,80 0,85% PharmaSGP